Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy

Circulation: Cardiovascular Imaging

Volumn 4, Issue 6, 2011, Pages 693-702

  Jellis, Christine ^b   Wright, Jeremy ^c   Kennedy, Dominic ^c   Sacre, Julian ^b   Jenkins, Carly ^b   Haluska, Brian ^b   Martin, Jennifer ^b   Fenwick, John ^c   Marwick, Thomas H ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

Diabetic cardiomyopathies; Diastolic dysfunction; Fibrosis; Magnetic resonance

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GADOBENATE DIMEGLUMINE; PROCOLLAGEN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD PRESSURE; CARBOXY TERMINAL SEQUENCE; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FUNCTIONAL DISEASE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEMODYNAMIC PARAMETERS; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, STRESS; ENDOMYOCARDIAL FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 82955173667     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.963587     Document Type: Article

References (33)

1. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003;41:611-617. (Pubitemid 36223327)
2. Fang ZY, Schull-Meade R, Downey M, Prins J, Marwick TH. Determinants of subclinical diabetic heart disease. Diabetologia. 2005;48:394-402. (Pubitemid 40543314)
3. Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW. Increased accumulation of the glycoxidation product N-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta. 2004;1636:82-89. (Pubitemid 38780784)
4. Sacre JW, Franjic B, Jellis CL, Jenkins C, Coombes JS, Marwick TH. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging. 2010;3: 1207-1215.
5. Benazzoug Y, Borchiellini C, Labat-Robert J, Robert L, Kern P. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture. Exp Gerontol. 1998;33:445-455. (Pubitemid 28354935)
6. Robins SP. Biochemistry and functional significance of collagen crosslinking. Biochem Soc Trans. 2007;35:849-852. (Pubitemid 350206380)
7. Sciarretta S, Paneni F, Palano F, Chin D, Tocci G, Rubattu S, Volpe M. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci (Lond). 2009;116:467-477.
8. Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I. Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol. 1993;46:32-36. (Pubitemid 23039583)
9. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595-602.
10. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbely A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117:43-51. (Pubitemid 350291180)
11. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113:1966-1973.
12. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med. 2007;4:436-443. (Pubitemid 47189016)
13. Diez J. Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich). 2007;9:546-550.
14. Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab. 2010;298:E897-E908.
15. Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ, Howell JF, Zoghbi WA, Nagueh SF. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol. 2000;36:891-896.
16. Picano E, Pelosi G, Marzilli M, Lattanzi F, Benassi A, Landini L, L'Abbate A. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation. 1990;81:58-64. (Pubitemid 20031767)
17. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for highresolution T1 mapping of the heart. Magn Reson Med. 2004;52:141-146. (Pubitemid 39295266)
18. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for Modified Look-Locker Inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging. 2007;26:1081-1086. (Pubitemid 47548170)
19. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.
20. Li W, Griswold M, Yu X. Rapid T1 mapping of mouse myocardium with saturation recovery Look-Locker method. Magn Reson Med. 2010;64: 1296-1303.
21. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574-1580.
22. Sibley CT, Noureldin RA, Gai N, Nacif MS, Mudd JO, Halushka MK, Bluemke DA. Cardiac MRI T1 mapping noninvasively predicts interstitial myocardial fibrosis in the absence of late gadolinium enhancement. Circulation. 2010;122:A19921. Abstract.
23. Sun JP, Popovic ZB, Greenberg NL, Xu XF, Asher CR, Stewart WJ, Thomas JD. Designation of tissue Doppler normal range. In: Marwick TH, Yu CM, Sun JP, eds. Myocardial Imaging: Tissue Doppler and Speckle Tracking. Malden, MA: Blackwell; 2007:36-51.
24. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410. (Pubitemid 32269192)
25. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542. (Pubitemid 34262671)
26. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution: reproducibility study. Radiology. 2006;238:1004-1012. (Pubitemid 43289933)
27. Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, Ichiki T, Harders GE, Chen HH, Burnett JC Jr. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide. Hypertension. 2011;57:201-207.
28. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-144.
29. Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, Siu S, Brown KA. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118:1011-1020.
30. Borlaug BA, Kass DA. Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc Med. 2006;16:273-279. (Pubitemid 44572803)
31. Kass DA. Getting better without AGE: new insights into the diabetic heart. Circ Res. 2003;92:704-706. (Pubitemid 36457632)
32. Ingul CB, Stoylen A, Slordahl SA, Wiseth R, Burgess M, Marwick TH. Automated analysis of myocardial deformation at dobutamine stress echocardiography: an angiographic validation. J Am Coll Cardiol. 2007; 49:1651-1659. (Pubitemid 46551633)
33. Gonzalez A, Lopez B, Ravassa S, Beaumont J, Arias T, Hermida N, Zudaire A, Diez J. Biochemical markers of myocardial remodelling in hypertensive heart disease. Cardiovasc Res. 2009;81:509-518.